Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Identification of single nucleotide polymorphisms in inflammatory bowel disease patients on azathioprine therapy
Dissertation (MSc)--University of Pretoria, 2019.
Saved in:
| Other Authors: | |
|---|---|
| Format: | Thesis |
| Language: | English |
| Published: |
University of Pretoria
2019
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1867613731514482688 |
|---|---|
| access_status_str | Open Access |
| author2 | Soma, Prashilla |
| author_browse | Soma, Prashilla |
| author_facet | Soma, Prashilla |
| collection | Thesis |
| dc_rights_str_mv | © 2019 University of Pretoria. All rights reserved. The copyright in this work vests in the University of Pretoria. No part of this work may be reproduced or transmitted in any form or by any means, without the prior written permission of the University of Pretoria. |
| description | Dissertation (MSc)--University of Pretoria, 2019. |
| format | Thesis |
| id | oai:repository.up.ac.za:2263/72719 |
| institution | University of Pretoria (South Africa) |
| language | English |
| last_indexed | 2026-06-10T12:40:48.647Z |
| license_str | Other — see source repository |
| provenance_str_mv | Harvested via OAI-PMH from UPSpace — University of Pretoria Institutional Repository |
| publishDate | 2019 |
| publishDateRange | 2019 |
| publishDateSort | 2019 |
| publisher | University of Pretoria |
| publisherStr | University of Pretoria |
| record_format | dspace |
| source_str | UPSpace — University of Pretoria Institutional Repository |
| spelling | oai:repository.up.ac.za:2263/72719 Identification of single nucleotide polymorphisms in inflammatory bowel disease patients on azathioprine therapy Soma, Prashilla u13020740@tuks.co.za Cromarty, Allan Duncan Phulukdaree, Alisa Adam, Lyla UCTD Inflammatory bowel disease (IBD) Azathioprine Single nucleotide polymorphism (SNP) Thiopurine methyltransferase (TPMT) Pharmacogenomics Health sciences theses SDG-03 Health sciences theses SDG-17 Dissertation (MSc)--University of Pretoria, 2019. Azathioprine, an immunosuppressant used for many years in the medical sector to maintain long term disease remission in inflammatory bowel disease has a side effect profile that has raised many concerns over the years with numerous studies into the risk, cause and prevention of these adverse events. It is estimated that 18 in every 100 000 South Africans suffer from Crohn's disease, while 5 in every 100 000 suffer from ulcerative colitis. Of these inflammatory bowel disease patients at least 20% will suffer from leukopenia and eventually bone marrow suppression. Much of the side effect profile of Azathioprine can be linked to a single nucleotide polymorphism in the thiopurine methyltransferase gene which ensures the breakdown and efficacy of Azathioprine. The thiopurine methyltransferase single nucleotide polymorphism profiles of various American, Asian and European populations have been studied, but little literature is available for the South African population. The aim of this study was to determine if it is essential to include "early warning" single nucleotide polymorphism testing in South African health care before treatment with Azathioprine is initiated. This was performed by evaluating 40 patients suffering from inflammatory bowel disease who met the inclusion/ exclusion criteria and who were on continuous Azathioprine therapy. The prevalence of *3A, *3B or *3C thiopurine methyltransferase gene SNP’s were determined to assess the efficacy of Azathioprine in reducing therapeutic markers and to compare the frequency of SNP’s within the Azathioprine dosing groups. This study showed an increase in the allelic frequency of thiopurine methyltransferase *3B and a statistically significant presence (p<0.001) of homozygous thiopurine methyltransferase *3B alleles in South African inflammatory bowel disease patients when compared to healthy South African individuals- this has not previously been reported in published literature. Thus, in future, the enzymatic effect of thiopurine methyltransferase *3B/*3B should be studied in a larger sample size prior to recommending early warning single nucleotide polymorphism testing in inflammatory bowel disease patient using Azathioprine as these results cannot be ignored. em2026 Pharmacology MSc Unrestricted SDG-03: Good health and well-being SDG-17: Partnerships for the goals 2019-12-13T08:07:48Z 2019-12-13T08:07:48Z 2019/09/06 2019 Dissertation Adam, L 2019, Identification of single nucleotide polymorphisms in inflammatory bowel disease patients on azathioprine therapy, MSc Dissertation, University of Pretoria, Pretoria, viewed yymmdd <http://hdl.handle.net/2263/72719> S2019 http://hdl.handle.net/2263/72719 en © 2019 University of Pretoria. All rights reserved. The copyright in this work vests in the University of Pretoria. No part of this work may be reproduced or transmitted in any form or by any means, without the prior written permission of the University of Pretoria. application/pdf University of Pretoria |
| spellingShingle | UCTD Inflammatory bowel disease (IBD) Azathioprine Single nucleotide polymorphism (SNP) Thiopurine methyltransferase (TPMT) Pharmacogenomics Health sciences theses SDG-03 Health sciences theses SDG-17 Identification of single nucleotide polymorphisms in inflammatory bowel disease patients on azathioprine therapy |
| title | Identification of single nucleotide polymorphisms in inflammatory bowel disease patients on azathioprine therapy |
| title_full | Identification of single nucleotide polymorphisms in inflammatory bowel disease patients on azathioprine therapy |
| title_fullStr | Identification of single nucleotide polymorphisms in inflammatory bowel disease patients on azathioprine therapy |
| title_full_unstemmed | Identification of single nucleotide polymorphisms in inflammatory bowel disease patients on azathioprine therapy |
| title_short | Identification of single nucleotide polymorphisms in inflammatory bowel disease patients on azathioprine therapy |
| title_sort | identification of single nucleotide polymorphisms in inflammatory bowel disease patients on azathioprine therapy |
| topic | UCTD Inflammatory bowel disease (IBD) Azathioprine Single nucleotide polymorphism (SNP) Thiopurine methyltransferase (TPMT) Pharmacogenomics Health sciences theses SDG-03 Health sciences theses SDG-17 |
| url | http://hdl.handle.net/2263/72719 |